Victoria Shi

Nov 19, 2024 | kevinmd.com | Harvey Castro |Alexander Le |Annie Y. Yao |Victoria Shi

Disclaimer: This is a broad generalization meant to spark reflection. While no one perfectly fits into generational boxes, these insights are designed to explore how each age group navigates the evolving world of artificial intelligence (AI). Generation Z (born 1997–2012): the digital nativesHow they see AI: AI is like oxygen for Gen Z—essential, omnipresent, and often unnoticed.

Oct 22, 2024 | kevinmd.com | Alexander Le |Annie Y. Yao |Victoria Shi |G. Richard Olds

As future medical professionals, we see the real-life consequences of political decisions in emergency rooms, hospitals, and clinics. Despite a growing recognition that voting is directly linked to better health outcomes, however, health professionals are voting at lower rates than the national average. It’s time that we make a change this election.

Oct 19, 2024 | americanjournalofsurgery.com | Tyler McKechnie |Kelly Brennan |Victoria Shi

KeywordsVenous ThromboembolismExtended Venous Thromboembolism ProphylaxisSurgeryMethodological SurveyFragility IndexGet full text accessLog in, subscribe or purchase for full access. References1. Sackett, D.L.Evidence-based medicineSemin Perinatol. 1997; 21:3-52. Sibbald, B. ∙ Roland, M. Understanding controlled trials. Why are randomised controlled trials important? BMJ. 1998; 316:2013. Murad, M.H. ∙ Asi, N. ∙ Alsawas, M. ... New evidence pyramidEvidence Based Medicine. 2016; 21:125-1274. Goodman, S.

May 29, 2024 | jamanetwork.com | Victoria Shi |Kansas City |Sneha Poondru |Anand Rajpara

In Reply We thank Adler et al for their insightful comments regarding our article1 and the treatment of lepromatous leprosy. As highlighted by these authors, the US National Hansen’s Disease Program (NHDP) has traditionally recommended treating multibacillary leprosy with daily rifampin, dapsone, and clofazimine for 24 months. However, as the authors mention, there have been recent new recommendations for monthly, rather than daily, multidrug leprosy therapy.

Nov 1, 2023 | jamanetwork.com | Sneha Poondru |Kansas City |Victoria Shi |Anand Rajpara

A man in his 30s with no relevant medical history presented to the dermatology clinic with a 3-year history of progressive nodules affecting his face and forearms. He also noted a 1-month history of blurry vision in his left eye. He was born in Micronesia and moved to the US in 2018. He had no close contacts with leprosy or individuals with skin conditions, and no other household members were affected. He did not have any notable animal exposures.